NovoSanis

Back

About Novosanis
Novosanis is a subsidiary of OraSure Technologies, Inc. Colli-Pee®, the heart of the company, allows volumetric and standardized first-void urine collection. The platform consists of variants capturing a range of urine volumes for different application purposes.

Why use first-void urine
Urine fractions are not the same. First-void urine, contains higher concentrations of analytes and biomarkers, compared to other fractions – for example, first-void urine contains more Human Papillomavirus (HPV) DNA than subsequent fractions. Strains of HPV are a major cause of cervical cancer. Additionally, first-void urine is important to identify biomarkers for other cancer types, including prostate and bladder cancer. To know more visit https://novosanis.com/oncology

Why use Colli-Pee
Collecting a first-void urine sample with a standard urine cup can be awkward, messy and inconvenient for the user. For this reason, Novosanis developed Colli-Pee®, a device that can be used by both men and women. Colli-Pee® allows for standardized, volumetric collection of first-void urine. The device architecture also enables immediate mixing of urine and preservative for adequate stability. To know more about the Colli-Pee device visit
https://novosanis.com/our-products





Back